Promise and Pitfalls of Animal Models of Schizophrenia

被引:0
|
作者
David Feifel
Paul D. Shilling
机构
[1] University of California,Department of Psychiatry
来源
Current Psychiatry Reports | 2010年 / 12卷
关键词
Animal models; Schizophrenia; Psychosis; Antipsychotics;
D O I
暂无
中图分类号
学科分类号
摘要
Animal models are indispensible tools for advancing understanding of the cause of any given disease and developing new treatments. Developing animal models for schizophrenia presents formidable challenges owing to the distinctively human nature of the symptoms that define it and the thus-far-obscured underlying biological mechanisms. Nevertheless, progress has been and continues to be made in this important field of endeavor. This article discusses the challenges facing investigators who seek to develop and use animal models for translational research in schizophrenia and the responses that have emerged to those challenges, as well as the likely pathways that will lead to future progress.
引用
收藏
页码:327 / 334
页数:7
相关论文
共 50 条
  • [21] Development of animal models for schizophrenia
    Arguello, P. Alexander
    Markx, Sander
    Gogos, Joseph A.
    Karayiorgou, Maria
    DISEASE MODELS & MECHANISMS, 2010, 3 (1-2) : 22 - 26
  • [22] Animal Models of Relevance to the Schizophrenia
    Petty, Alice
    Howes, Oliver
    Eyles, Darryl
    BIOLOGICAL PSYCHIATRY: GLOBAL OPEN SCIENCE, 2023, 3 (01): : 22 - 32
  • [23] Pathophysiology and Animal Models of Schizophrenia
    Dawe, Gavin S.
    Hwang, Ern Huei Joel
    Tan, Chay Hoon
    ANNALS ACADEMY OF MEDICINE SINGAPORE, 2009, 38 (05) : 425 - 430
  • [24] Estimating animal abundance using noninvasive DNA sampling: Promise and pitfalls
    Mills, LS
    Citta, JJ
    Lair, KP
    Schwartz, MK
    Tallmon, DA
    ECOLOGICAL APPLICATIONS, 2000, 10 (01) : 283 - 294
  • [25] Glutamatergic animal models of schizophrenia
    Moghaddam, B
    Jackson, ME
    GLUTAMATE AND DISORDERS OF COGNITION AND MOTIVATION, 2003, 1003 : 131 - 137
  • [26] Pharmacogenomics and animal models of schizophrenia
    Klink, R
    Boksa, P
    Joober, R
    DRUG DEVELOPMENT RESEARCH, 2003, 60 (02) : 95 - 103
  • [27] Glutamatergic Animal Models of Schizophrenia
    Bondi, Corina
    Matthews, Marguerite
    Moghaddam, Bita
    CURRENT PHARMACEUTICAL DESIGN, 2012, 18 (12) : 1593 - 1604
  • [28] ANIMAL-MODELS OF ATHEROSCLEROSIS - THEIR CONTRIBUTIONS AND PITFALLS
    VESSELINOVITCH, D
    ARTERY, 1979, 5 (03) : 193 - 206
  • [29] Liraglutide: the therapeutic promise from animal models
    Knudsen, L. B.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2010, 64 : 4 - 11
  • [30] ANIMAL-MODELS FOR SCHIZOPHRENIA - THE HIPPOCAMPALLY LESIONED ANIMAL
    SCHMAJUK, NA
    SCHIZOPHRENIA BULLETIN, 1987, 13 (02) : 317 - 327